Company intelligence / Profile preview

Terapia Ranbaxy

Cluj-Napoca, Cluj, Romania

Ownership: Private
Employees: ~850
Development stage: Other

Overview

Terapia is the largest generic pharmaceutical company in Romania, with a history dating back to 1921. Following its acquisition by Ranbaxy in 2006 and the subsequent merger of Ranbaxy into Sun Pharma in 2015, the company operates as a key subsidiary of Sun Pharmaceutical Industries. Terapia focuses on the development, manufacturing, and distribution of a wide range of generic medicines across various therapeutic areas, including cardiovascular, central nervous system, and musculoskeletal disorders. The company maintains significant manufacturing facilities in Cluj-Napoca and serves both the Romanian domestic market and numerous export markets.

Therapeutic areas: CardiovascularNeurologyGastroenterologyRheumatologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Terapia Ranbaxy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terapia Ranbaxy.

Explore the full profile